| O95398 |
RPGF3_HUMAN |
Epidermal dysplasias [ICD-11: EK90] |
| P43220 |
GLP1R_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
| P43220 |
GLP1R_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
| P43220 |
GLP1R_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
| P43220 |
GLP1R_HUMAN |
Type-1/2 diabete [ICD-11: 5A10-5A11] |
| P43220 |
GLP1R_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
| P43220 |
GLP1R_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
| P43220 |
GLP1R_HUMAN |
Dyspepsia [ICD-11: MD92] |
| P43220 |
GLP1R_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
| P43220 |
GLP1R_HUMAN |
Intracranial injury [ICD-11: NA07] |
| P43220 |
GLP1R_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
| P53350 |
PLK1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
| P53350 |
PLK1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
| P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P53350 |
PLK1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
| P53350 |
PLK1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| P53350 |
PLK1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
| P53350 |
PLK1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
| P53350 |
PLK1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
| P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P84022 |
SMAD3_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
| P84022 |
SMAD3_HUMAN |
Kidney fibrosis [ICD-11: GC01] |
| Q14191 |
WRN_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
| P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
| P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
| P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
| P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
| O94782 |
UBP1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q13526 |
PIN1_HUMAN |
Lung cancer [ICD-11: 2C25] |
| Q13526 |
PIN1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |